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 Executive summary 
 
This report reviews how the guidance on Safeguarding Children in Whom Illness 
is Fabricated or Induced 1 is being implemented within NHS settings. The review 
followed a number of high profile serious case reviews highlighting system 
weaknesses in safeguarding children and young people. The review was 
established to consider how resilient the health system is in safeguarding 
children and young people being deliberately harmed by family and carers. The 
review was overseen by an Advisory Body of key stakeholders and individual 
experts. 
 
The key findings of the review are drawn from a survey of NHS and social care 
staff attitudes on fabricated or induced illness, one-to-one interviews, focus 
groups and an analysis of serious case reviews in the public domain.   
 
The survey provided evidence on staff attitudes to fabricated or induced illness 
and experience of managing cases in the context of organisational and multi-
agency frameworks. 535 responses were received, which although self-selecting 
would allow some inferences about the views of staff working in the NHS to be 
drawn. Key findings highlight the following:  
 
• Greater knowledge of the existence of the fabricated and induced 
guidance is needed amongst all NHS staff, (including paediatricians 
and generalists in a wide range of health services such as 
unscheduled care); 
 
•  More focused implementation of the guidance through better and 
shared multi-agency protocols and joint training;  
 
• Better management of suspected cases, both clinically and in relation 
to co-ordination by local authority children’s services; and 
 
• Continuing personal anxiety amongst paediatricians about the 
implications of identifying fabricated or induced illness rightly or 
wrongly. 
 
 
Summary of proposals 
 
1. The Department for Children, Schools and Families and the Department of 
Health should agree ways to promote the revised guidance on 
Safeguarding Children in Whom Illness is Fabricated or Induced  (2008)3  
so it is promoted extensively in the NHS and by the professional bodies. 
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Ways should be found to bring it to the attention of private health providers 
of children’s services, including providers of complementary therapies.  
 
2. There needs to be wide-ranging readership of the guidance outside 
paediatric services. The Department for Children, Schools and Families 
and the Department of Health should consider an abridged or flowchart 
version for promotion in these various services on the basis of “what to do 
if fabricated or induced illness is suspected.” 
 
3. When revising the report, Fabricated or Induced Illness by Carers, the 
Royal College of Paediatrics and Child Health should work collaboratively 
with the Academy of Medical Royal Colleges, the Nursing, Midwifery and 
other Royal Colleges, the Royal Pharmaceutical Society and other 
relevant professional bodies to make it a shared inter-collegiate document 
that is brought to the attention of a wide range of health care staff. 
 
4. Primary Care Trusts, NHS Trusts and Foundation Trusts’ Boards should 
ensure that as part of working on effective arrangements within their Local 
Safeguarding Children Boards, they have robust arrangements in place for 
promoting the revised guidance,and for uptake of staff induction on 
safeguarding children and young people, which includes a focus on 
fabricated or induced illness and the role of named and designated 
professionals and how they can be contacted.    
 
5. As requested in 2006 by the Department of Health, the development of 
guidelines by the National Institute of Clinical Excellence on suspected 
child abuse should include identification of fabricated or induced illness. 
 
6. Clinical Medical Directors of paediatric services should ensure robust 
arrangements are in place in their NHS Trusts, Foundation Trusts or 
Primary Care Trusts to enable consultant paediatricians to have access to 
teams within their Trusts and across to other clinical networks outside their 
organisations, to discuss clinical concerns about identification, diagnosis 
and clinical management of fabricated or induced illness cases. 
 
7. As a general development to support more effective information on 
safeguarding children and young people, the development of the Care 
Services Improvement Partnership safeguarding children networks and 
website, and the plans to look at the feasibility of extending it to clinicians 
beyond designated and named doctors and nurses by providing a supra 
secure discussion forum for complex and forensic cases, is to be 
welcomed.  
 
8. The revision of the guidance (Safeguarding Children in Whom Illness is 
Fabricated or Induced ( 2008)) 3] to take account of changes to Working 
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Together to Safeguard Children is timely, and in the light of the findings of 
this Review welcome that the changes being made will:  
 
• Emphasize the necessity for all staff to be aware of their Trusts’ and 
Local  Safeguarding Children Board’s policies and practices;   
 
• Clarify the co-ordinating role of the lead paediatricians vis-a-vis the 
consultant in charge of the child’s care if the consultant is not a 
paediatrician;  
 
• Include a pathways chart of responsibilities and actions to be taken 
which will cover what to do where fabrication is identified to be at the 
lower level or where the evidence of fabricated or induced illness is 
less certain;  
 
• Make more prominent in the pathways chart the need always to talk 
directly and involve the child or young person, where possible;  
 
• Affirm resolution protocols to be in place to support staff when 
professional conflict arises over identification, diagnostic and 
management decisions. 
 
9. That the Healthcare Commission has regard for the content of this report 
in its assessment and inspection arrangements. 
  
10. As part of promoting the revised guidance on fabricated or induced illness, 
the Department for Children, Schools and Families should: 
 
• Remind Local Safeguarding Children Boards to incorporate the 
guidance into their local procedures and training, setting out in clear 
terms what is expected of adult mental health services, primary care 
and general practice and collaboration with the police and other 
agencies. 
 
• Ask Local Safeguarding Children Boards to ensure that their members, 
including Primary Care Trusts, NHS Trusts and Foundation Trusts, 
bring the guidance to the attention of all their staff, in accessible 
formats, promoting the pathways chart on fabricated or induced illness 
to clinicians and staff in all age specialties and services where children 
and young people are seen. 
 
11. Widely promote the Department for Children, Schools and Families’ 
forthcoming training resources on fabricated or induced illness, Incredibly 
Caring DVD, which is designed to assist with local implementation of the 
revised guidance Safeguarding Children in Whom Illness is Fabricated or 
Induced (2008)]. 
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12. When the revised guidance is published, Local Safeguarding Children 
Boards should be asked to ensure that their multi-disciplinary and inter-
agency safeguarding training programmes include fabricated or induced 
illness. 
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 CHAPTER 1 
 
1.0 BACKGROUND  
 
 
1.1. In 2004, Department of Health Ministers asked the Government’s Chief 
Medical Officer, Sir Liam Donaldson, to review how the guidance on 
Safeguarding Children in Whom Illness is Fabricated or Induced 1 was 
being implemented within the NHS. This is supplementary guidance to 
Working Together to Safeguard Children 4.  The review was to consider 
how resilient the health system is in safeguarding children being harmed 
deliberately or suspected of being harmed by their families or carers, 
including when a child is receiving care within an NHS setting.  
 
1.2. This review follows a number of high profile serious case reviews 
highlighting system weaknesses in safeguarding children and young 
people and a report by the Royal College of Paediatrics and Child  
Health 5. This  highlighted how criticism of doctors in the media, high 
profile court cases and disciplinary action being taken by the General 
Medical Council, the medical regulatory body, was deterring some 
paediatricians from undertaking child protection work.  
 
1.3. The statutory inquiry into the death of Victoria Climbie 6, and the  
first joint Chief Inspector’s Report on safeguarding children 7, had 
identified the lack of priority status given to safeguarding matters within 
some NHS organisations and led to a range of developments across 
children’s services under the Every Child Matters 8 agenda and the 
provisions in the Children Act 2004 9. This guidance and statutory 
provision placed a duty on all agencies to make arrangements to 
safeguard and promote the welfare of children, identifying the shared 
responsibility of safeguarding and the need for effective joint working 
between agencies and professionals who have different roles and 
expertise in promoting the welfare of children and protecting them from 
harm.  Nationally, the responsibility for children’s services and 
safeguarding them sits with the Department for Children, Schools and 
Families supported by other government departments including the 
Department of Health. 
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The review terms of reference 
 
1.4      The purpose of the review was set out as follows:  
 
• To review implementation of the guidance on Safeguarding Children in 
Whom Illness is Induced or Fabricated 1 in the NHS and assess if more 
effective implementation can be achieved by focusing on: 
 
• Clarity, accessibility and implementation of procedures in 
Primary Care Trusts, NHS and Foundation Trusts for 
safeguarding children, for identifying and managing child abuse 
and for reporting incidences. These should be integrated into 
each Trust’s clinical governance arrangements;  
 
• Paediatricians’ experience and views on responsibilities in 
handling individual cases especially in relation to child welfare 
concerns, identification of fabricated or induced illness in cases 
where there may be clear grounds to believe a child is suffering 
or is at risk of suffering significant harm, comprehensive medical 
evaluation, referral, contribution to assessments under the 
Children Act 1989 10  and implementation of actions agreed;  
 
• On the matter of comprehensive medical evaluation, the review 
to take into account implementation of the relevant 
recommendations of Lord Laming’s report 6 as endorsed by the 
Government’s response especially and including the need to 
take a history directly from the child even when the consent of 
the carer has not been obtained;  
 
• In terms of information collection, a review of how all the 
information available is collated, integrated together and 
systematically organised to ensure co-ordination of care with 
clear discussion to reconcile differences in medical opinion 
about diagnosis of deliberate harm and with a single consultant 
charged with the responsibility for the child protection aspects of 
the case and hospital discharge procedures. The review should 
reflect the report on clinical issues produced in February 2002 
by the Royal College of Paediatrics and Child Health 5, which 
advises on professionals suspending disbelief and putting the 
interests of the child foremost through application of 
competence and protocols;  
 
• The views and understanding of members of multi-disciplinary 
clinical teams, named and designated professionals in relation 
to the above points.  
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• To draw out lessons to be learnt from the review of cases about 
potential areas of vulnerability in the way current guidance on 
fabricated or induced illness is being implemented.  
 
1.5 The review was supported by an Advisory Group, with representation   
from key stakeholder bodies (Annex A ). The remit of the Advisory Group 
was:  
 
“To improve NHS protection of children by advising the Department’s 
review of NHS implementation of guidance on fabricated or induced 
illness. In particular, to advise on the conduct of the review and to quality 
assure the findings as they emerge from the review”.      
 
Gathering the information 
 
1.6 The review drew on the following sources of research, information and   
opinions: 
 
• An online anonymous staff attitude survey on the extent of the 
awareness of existing fabricated or induced illness guidance and how it 
is used; 
 
• An analysis of serious case reviews that were available in the public 
domain since the fabricated or induced illness guidance was published 
in 2002; 
 
• Semi-structured interviews with individuals involved in fabricated or 
induced illness work, with a particular focus on paediatricians; and  
 
• Focus groups to test the emerging themes from the staff attitude 
survey and follow-up telephone interviews undertaken, the serious 
case review analysis and the semi-structured interviews. 
  
1.7  Originally, it had been planned the review would take a year to complete 
and report. However, the sensitive nature of the subject matter required 
careful development of the methodology to be used. The Advisory Group 
was consulted on the best way forward and used as a sounding board in 
the planning of the review processes, thus ensuring that once the review 
work commenced, it was able to move forward without hindrance. 
 
 
The approach in this report 
 
1.8 The four approaches set out above contributed to the overall findings of 
this report, which provides: 
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• A review of the evidence and relevant policy on fabricated or  
induced illness 
 
• Key findings from the information gathering 
 
• Issues and challenges in the system  
 
• Proposals for improving implementation of fabricated or induced  
illness guidance in the NHS.  
 
1.9 Throughout this report when referring to the 2002 guidance on 
Safeguarding Children in Whom Illness is Fabricated or Induced,  
the term “the guidance” is used.  
 
1.10    Children’s services are used to describe local authority social services. 
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CHAPTER 2 
he evidence  
2.1 
r 
with 
ying chronic illness. Multiple 
2.2  
 
 
•  
brications, withholding (nutrients or medicine) or inducing 
• 
 
2.0 FABRICATED OR INDUCED 
ILLNESS - EVIDENCE, POLICY 
CONTEXT AND PERFORMANCE 
SSESSMENT A
 
 
T
 
Fabricated or induced illness - previously known as Munchausen 
syndrome by proxy (MSBP) - is a rare condition, in which a parent or care
fabricates or induces illness or injury in others, most usually a child, 
no obvious motive or gain. A two-year study of the epidemiology of 
fabricated or induced illness published in 1996 suggested, “in a 
hypothetical district of one million inhabitants, the expected incidence 
would be approximately one child per year.” 11 A prevalence of 0.1 – 0.8 
per 100,000 children under 16 years old was suggested in that study of 
child protection registrations but 2 per 100,000 was reported for the same 
age group in a later study in New Zealand, when awareness had improved 
12. Half of those were associated with underl
symptoms featured in 72% of those cases.  
 
In fabricated or induced illness, there may be a spectrum of behaviours of
varying severity in impact on the child, ranging from fabricated illness 
where signs and symptoms are fabricated, to induced illness where there
is direct interference and harm. Fabrication is present in most cases of 
induced illness. For both fabricated and induced illness, specimens may 
be falsified to support the story. An unpublished study, the Northern 
Borough Study (2) by Eminson, Watson and Coupe in 1999, identified 58 
children from 42 families who had been subject to the behaviours, of 
whom six had suffered direct inductions. A literature review involving 566 
papers with 677 index cases by Postlethwaite, Eminson and Vail, 2006, 
published in abstract only at present, found the following characteristics: 
 
The physical impact on children escalates according to whether it is
verbal fa
illness; 
 
Death of the index case is highly associated with  
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inductions by toxicity;  the relationship for siblings is less clear cut; 
 
rications may not progress over many years to induction 
attempts; 
 Perpetrators are predominantly female; 
•  abuse 
lties, a pre-existing mental illness or substance 
misuse problem; 
 
• Other child abuse is commonly present; and 
 
•  co-exist with an underlying medical 
2.3  n-
te severely 
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2.4 s 
s 
d by the American Professional Society on the 
2.5 
n which children present, 
2.6 
he 
d 
• Verbal fab
 
•
 
Some perpetrators had existing vulnerabilities such as childhood
or neglect; somatic focus on self; personality traits or disorders; 
relationship difficu
Fabrication or induced illness can
condition in the child.  
 
The literature available affirms that the medical system’s ‘investigatio
orientated fascination with rare conditions,” inadvertently provides a 
readily available vehicle for enabling parents to perpetua  
abusive behaviours on children through induced illness.”
 
The use of different terminology to describe fabricated or induced illnes
has been the subject of considerable debate between professionals. 
Terms used include Munchausen’s Syndrome by Proxy 14 or Factitiou
Illness by Proxy 15,16 or Illness Induction syndrome17. Fabricated or 
induced illness rightly puts the focus on the child and the harm being 
suffered, rather than the perpetrator. The term Paediatric Condition 
Falsification is adopte
Abuse of Children.   
 
Fabricated or induced illness is a form of child abuse and may itself co-
exist with other types of child abuse. The range of symptoms and body 
systems involved in the spectrum of fabricated or induced illness are 
extremely wide, as can be the medical services i
spanning primary, secondary and tertiary care.  
 
Despite the unequivocal evidence that carers can and do cause harm to 
children through fabricated or induced illness, recognising, identifying and 
accepting fabricated or induced illness is present is not easy and may 
require clinicians to suspend their disbelief, maintaining the welfare of t
child as a priority.  Amongst some clinicians, there is a reluctance to 
diagnose and be involved in child abuse cases 18. A number of factors 
appear to contribute to this, amongst them fear of complaints whether 
locally or to the General Medical Council 19, pressure from the media an
parent groups representing those who believe their children have been 
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wrongly identified as a case of fabricated or induced illness, difficulties
with multi-agency working and a strong sense of being isolated w
 
hen 
involved in a contentious case of fabricated or induced illness.   
2.7 
r 
ny issues related to the epidemiology of 
fabricated or induced illness.  
2.8  
s 
, 
on the 
outcomes of interventions both in actual or suspected cases.    
he policy context  
2.9 
 and 
 as 
tion of 
 
 is 
nsideration of how best to safeguard and promote the 
child’s welfare.       
2.10 
s, 
ocal child protection procedures by 
Local Safeguarding Children Boards. 
2.11 the 
 
 
A literature review of ‘Munchausen Syndrome by Proxy’ carried out in 
2000 20 concluded that the professional community was now more aware 
of the situations and presentations of the condition and suggested furthe
work is done to identify the ma
 
However, a search of a range of databases for literature and papers on
fabricated or induced illness or however called, published since 2002, 
revealed a small number of relevant citations. The majority were review
of previous literature, case reports, and discussions on ethical issues
journal letters or reports on court cases. There is a dearth of recent 
publications which review the epidemiology and next to nothing 
 
 
T
 
Guidance on Safeguarding Children in Whom Illness is Fabricated or 
Induced 1  provides a national framework within which agencies and 
professionals at local level – individually and jointly – should draw up
agree more detailed ways of working together where illness may be 
fabricated or induced in a child. To keep the child’s safety and welfare
the primary focus of all professional activity and avoid difficulties with 
differences of opinion, the guidance refers to the “fabrication or induc
illness in a child”. The guidance is intended to provide a process for 
professionals to follow if, as a result of a parent’s or carer’s behaviour or
investigations, there is concern a child is suffering significant harm or
likely to do so. The key issue is the impact on the child’s health and 
development and co
 
The guidance makes foremost the importance of working together across 
health, education services, social services, police, probation services and 
with others whose work brings them into contact with children and familie
including people working in the voluntary and independent sectors. The 
guidance should be incorporated into l
 
Earlier in the same year as the first edition of the guidance was issued, 
Royal College of Paediatrics and Child Health published Fabricated or 
Induced Illness by Carers 5 which deals with the clinical issues in more 
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detail. The College report provides practical advice for paediatricians on
their role and how they can work with other agencies. It recognises th
difficulties professionals may experience and the need to overcome 
incomprehension and disbelief when faced with the possibility of this form 
child abuse. Both the guidance and the Royal College of Paediatrics a
Child Healt
 
e 
of 
nd 
h report also provide a brief overview of the literature and 
research.  
2.12 
02, Lord 
 
ge 
y puts 
for 
ve 
me throughout, in addition to being a dedicated 
service standard 25 . 
2.13 
gic 
elfare of children and participate on 
Local Safeguarding Children Boards 
2.14 s 
 fabricated 
en published, will be accompanied with support 
materials on training.  
Performance assessment 
2.15
 
 
Sir Ian Kennedy’s 2001 report on children’s heart services in Bristol 21, the 
First joint Chief Inspectors’ Report on Safeguarding Children 7 in 20
Laming’s report on the inquiry into the death of Victoria Climbie in  
2003 6 and Sir Michael Bichard’s report into the child protection procedures
in Humberside Police and Cambridgeshire Constabulary in 2004 following 
the murders of Jessica Chapman and Holly Wells 22, all highlighted a ran
of serious problems in the system in place to safeguard children. In the 
Government’s systematic programme of work to improve outcomes for 
children, being safe and healthy are amongst five priorities that children and 
young people themselves identified 23. The resulting vision and strateg
children at the heart of public services and was set out in Every Child 
Matters 8,24. The five key outcomes have a statutory underpinning in the 
Children Act 2004 9. At the same time, the National Service Framework 
Children, Young People and Maternity Services, to be implemented by 
2014, set standards for health, education and social services which ha
safeguarding as a the
 
Following the enactment of the Children Act 2004, a series of statutory 
guidance 26 was published to support local authorities and their partners, 
including Primary Care Trusts, NHS Trusts, Foundation Trusts and Strate
Health Authorities, to implement their new statutory duties, including the 
need to safeguard and promote the w
 
An updated version of Working Together to Safeguard Children 4 wa
published in April 2006, following changes to safeguarding children 
processes arising from the 2004 Children Act 9 .The guidance on
or induced illness is currently being revised in the light of these 
developments and, wh
 
 
 
 The planning framework for health services from 2005/08 , set out in 
National Standards Local Action published in July 2004, 27  details core 
standards to be complied with now, and developmental standards to be
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complied with over time. Child protection (C2 is a core standard to be 
complied with now. The National Service Framework for Children, Y
People and Maternity Services, for implementation by 2014, has a 
dedicated safeguarding children sta
oung 
ndard and a recurrent safeguarding 
theme in the other ten standards.   
2.16 nd 
f 
ratory process from NHS Boards 
against core standard C2 which states: 
 
in their own activities and in their dealings with 
other organisations.” 27  
2.17 
 for 
 
ted 
 outcomes are set out in the annual health check 
d in 2007 28.  
2.18 
 and clinical 
king systems and practices and patient safety.  
Core standard C7 states:  
 
ke systematic risk assessment and 
sk management.” 27  
2.19
of this core 
 and 
 
In its function of encouraging improvement in the delivery of healthcare a
public health in England, the Healthcare Commission has a duty to pay 
particular attention to the need to safeguard children and young people, 
promote the rights and welfare of children and promote the effectiveness o
measures taken to do so. The Commission does so through a number of 
ways. Its annual health check of NHS performance covers safeguarding 
children by a self-assessment and decla
“Healthcare organisations protect children by following national child 
protection guidelines with
 
Self-declarations are checked against surveillance information and 
supplemented by comments from patient representatives and partners of 
the health bodies. 10% of health organisations are randomly selected
inspection of their declaration. For 2006/7, as part of the process of 
checking, the Commission invited  Chairs of Local Safeguarding Children
Boards to comment on the declarations from their Primary Care Trusts, 
NHS Trusts and Foundation Trusts and in particular, whether each Trust 
complies with national guidance in relation to cases of suspected fabrica
or induced illness. The
publishe
   
There is also a core standard C7 in the governance domain.This is framed 
to ensure healthcare organisations are providing the managerial
leadership, accountability and culture necessary for continuous 
improvement, effective wor
”Healthcare organisations: (a) apply the principles of sound clinical and 
corporate governance, …, (c) underta
ri
 
 The governance issues in safeguarding children and young people and safe 
systems of care are not specifically picked up in the assessment 
standard C7 and, although the assessment of C2 includes such 
responsibilities as Trust Boards’ arrangements for safeguarding, it does not 
pick up the issues of risk management in systems to safeguard children
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young people who are in hospital care. A recommendation is therefore 
 
2.20 
es 
are 
o have 
2.21 
e 
help 
r 
 a 
rding. Improvement is 
being tracked through the annual Child Health Services Mapping project 30 
 
2.22 
 are 
nd 
 welfare 
been 
dvised to consider how they effect this responsibility across the multiple 
2.23 ed 
fabricated or induced illness 
in the health services. Chapter 3 reports the findings of the review and 
proposals for action are set out in Chapter 4.  
proposed in chapter 4 of this review report.  
Working with Ofsted and the other national Inspectorates, joint area reviews 
are conducted every three years in every local authority that provid
children’s services, to look at the impact that local services and partnerships 
have on the outcomes experienced by children and families. The 
Inspectorates have recently changed the way in which joint area reviews 
undertaken to focus more closely on the experiences of children wh
the poorest outcomes, including those with disabilities and those looked 
after by local authorities. Safeguarding children remains a priority. 
Improvement reviews are another type of independent assessment 
undertaken by the Commission to look at the quality of care provided by th
health services, especially where there are substantial opportunities to 
healthcare organisations to identify where and how they could improve o
perform better. A review published this year on services for children in 
hospital reported serious concerns about quality and safety of care in a 
small number of trusts 29. Furthermore, child protection was identified as
major risk, with 58% of hospital services accessed by children and young 
people not meeting training standards in safegua
and annual performance assessment of trusts.  
Strategic Health Authorities set and manage the strategic direction of the 
NHS locally. They have a role both in ensuring local systems operate 
effectively and deliver improved health services, and that local services
of high quality and performing well. Strategic Health Authorities have a role 
in managing Trusts’ performance against the core and developmental 
standards and Trusts’ implementation of serious case review action plans. 
The duty in the Children Act 2004 9 to co-operate with local authorities a
their partners to make arrangements to safeguard and promote the
of children applies to Strategic Health Authorities, Primary Care Trusts, 
Foundation Trusts and NHS Trusts, as does membership of Local 
Safeguarding Children Boards. Strategic Health Authorities have 
a
local Safeguarding Children Boards authorities in their areas 31.  
 
The prominent safeguarding policy and performance framework describ
above needs to bite even more on addressing 
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Chapter 3 
 
3.0 KEY FINDINGS AND 
HALLENGES C
 
The main findings of the Review are presented in this chapter. The 
methods used to gather the information are summarised at Annex B.  
3.1 
 
  staff attitudes with a telephone 
• r  
s that have been published since the guidance 1 was 
 
• ad 
abricated or induced illness (of whom 10 
 
• 
.   
3.2  
some 
3.3 he 
 
d 
Evidence was gathered from the four main sources below:  
An online and anonymous survey on•
follow-up of 22 of the respondents; 
 
Analysis of overview reports of four serious case reviews on fab icated
or induced illnes
issued in 2002; 
Individual semi-structured conversations with 21 professionals who h
been involved in cases of f
were paediatricians) and  
Seven focus groups to test the emerging findings with a wider range of 
staff (including GPs, education, police and health service managers)
 
The online survey targeted NHS staff and children’s services staff who
work with the health sector (Annex C).  It provides evidence on staff 
attitudes to fabricated or induced illness and experience of managing 
cases in the context of organisational and multi-agency frameworks. 535 
responses were received, which although self-selecting would allow 
inferences about the views of staff working in the NHS to be drawn. 
 
Consultant paediatricians and staff in a variety of “other roles” formed t
majority of respondents -194 and 198 respectively (Annex D).  “Other 
roles” comprised medical consultants other than paediatricians and 
included general practitioners, other doctors who were not consultant 
grade, nurses working in a variety of specialties, midwives, allied health 
professionals and social workers. The third largest group was specialist 
child protection staff i.e. health visitors, school nurses and nurse 
consultants in child protection or safeguarding roles (Table 1). Almost two 
thirds of all respondents (63%) could be described as having safeguarding
children as an intrinsic part of their jobs i.e. consultant paediatricians an
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specialist child protection staff. Where relevant, results were analysed 
ge, use and usefulness of guidance on fabricated or induced 
 
3.4 in 
s 
 
t the 
als’ 
d or Induced Illness  from the Royal College of Paediatrics and 
Child Health but less than half of specialist child protection staff knew 
about it. 
able 1: Numbers and proportions o ts by knowledge of gu ance and 
taff group (n=535) 
further by designated/named professional roles a.  
 
nowledK
illness  
 
Knowledge and use 
73% of survey respondents knew about the guidance prior to taking part 
the survey (Table 1). Expectedly, knowledge about the guidance wa
higher amongst consultant paediatricians and specialist child protection
staff. Amongst staff in other roles, a lower proportion than could be 
expected knew of the guidance (55%). It is worrying that almost half of 
staff in “other roles” who see children in their work did not know abou
guidance. Surprisingly, 15% of paediatricians and 16% of specialist child 
protection staff also did not know. The finding is consistent with the 
analysis of serious case reviews where a recurrent theme is profession
lack of knowledge of fabricated or induced illness. By contrast, almost all 
consultant paediatricians (91%) knew of the Working Party Report on 
Fabricate 5
 
T
s
f responden id
 Staff Group 
 
 
wledge C  onsultant
Paediatrician 
Specialist Child O  ther Role Total Kno
Protection Knowledge 
NO 30 (15%) 23 (16%) 89 (45%) 142 (27%) 
YES 164 (85%) 120 (84%) 109 (55%) 393 (73%) 
Total Staff 194 (100%) 143 (100%) 198 (100%) 535 (100%) 
 
3.5 
ildren, 
ually came to their attention once a case of fabricated or 
                                         
The structured conversations and focus group discussions indicated that 
for many who do not work expressly in the area of safeguarding ch
the guidance us
   
gnated’ and ‘named professionals’ have specific roles and responsibilities for safeguarding children 
in Primary Care Trusts and provider trusts respectively. The designated doctor and nurse provide strategic 
a Desi
safeguarding leadership in commissioning organisations and to named professionals. Named doctors and 
nurses promote good professional practice within trusts and advise staff on safeguarding issues within the 
organisations. If not already a board level director themselves, they should be accountable to such a director 
in their organisation who has executive responsibility for safeguarding children as part of their portfolio of 
responsibilities.  
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induced illness was suspected and identified. This was said to be 
unsatisfactory. 
 
 
 
“Too often teams seem to learn on the case and this leads to clumsiness in 
dealing with the issues.” 
 
 
 
3.6 
s 
r 
ogy 
nise 
those functions and roles in identifying and managing cases of fabricated 
or induced illness. Others suggested that organisational changes in the 
NHS since 2002 may have hindered effective incorporation of the 
There was insufficient evidence from the survey to suggest any 
association between knowledge of the guidance and type of NHS 
organisation. Nonetheless, it was thought by some that one of the reason
the guidance appeared to be overlooked in some care services -fo
example ambulance services, NHS Direct, unscheduled care, toxicol
and pathology - might be because it did not fully encompass or recog
guidance into local procedures and training (training is discussed at 
paragraph 3.34 – 3.39 below). However, one respondent disclosed: 
 
 
 
“I have recently taken up a new post in a new area, and now we have a case and 
I have been surprised at the lack of knowledge within all service areas. In my last 
area, we carried out a great deal of multi-agency training and ensured all were 
aware of the guidance. It appears nothing was done in my new area.” 
 
 
…. another respondent said: 
 
 
“Although there have been [national] guidelines I am not aware of any change in 
trust policy” 
 
 
Useful uidance 
ced illness were almost split evenly (Table 2). 
Those who had dealt with a case were more likely to know about the 
guidance.   
ness of the g
 
3.7 The numbers of consultant paediatricians who had dealt/not dealt with a 
case of fabricated or indu
 22
Table 2: Consultant paediatric nowledge ce and whether they 
se (n=19
ians by k of guidan
have dealt with a ca 3) 
 
  Dealt with a Case 
 
 
Know dge le NO YES Total Knowledge 
NO 21 (21%) 9 (10%) 30 (16%) 
YES 78 (79%) 85 (90%) 163 (84%) 
Total dealt with a case 99 (100%) 94 (100%) 193 (100%) 
 
 of survey respondents who knew about the guidance found it useful 
uding 
igure 1: Proportion of respondents that f e useful in their work 
=393) b
                                           
 
3.8 66%
in their work whilst 29% had never used it (Figure 1).  Excl
respondents who have never used the guidance, 93% of all respondents 
found the guidance useful.    
 
F ind the guidanc
(n
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NO 
5% 
(21) 
Have never used 
the guidance 
29% 
(113) 
 
YES 
66% 
(250) 
b Only the responses of those that confirmed they had prior knowledge of the guidance are 
included.  
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 3.9 Overall, the majority of respondents who had knowledge of the guidance 
s such that consultant 
4%) found it less useful 
than staff in specialist child protections roles i.e. nurses (17%). The most 
 
.10 Excluding those who had never used the guidance, 13% of consultant 
d not find the guidance to be useful (main statistical 
report). The reason suggested in the interviews and focus groups was to 
found it useful but there were notable difference
paediatricians (40%) and those in other roles (4
common reasons for the guidance being useful was because it “clarified 
the position” (70%), followed by help “in involving multi-agency partners” 
(61%) – Figure 2.  
 
Figure 2: Why the guidance is useful (n= 255)  
 
 
3
paediatricians, 8% of staff in other roles and 1% of specialist child 
protection staff di
do with cases where there was uncertainty about diagnosis and what 
should be done in those circumstances: 
 
 
“The problem with the guidelines is that they are less good when dealing with the 
ambiguous situations”. 
 
“Clearer guidance is needed to manage cases before a diagnosis has been 
made of FII an,d when there [is] a suspicion, how this can be managed”  
0 
 
40 
60 
8
100
1
1
1
200 
180 
60 
40 
20 
 
0 
20
Other  Helped to answer 
my questions 
Showed me how 
to address my 
concerns 
Gave me route to 
safeguard the 
child 
Helped resolve 
professional 
conflicts
Made the way 
forward clearer 
Assisted me in 
involving multi 
agency partners 
Clarifie
positio
 
d the
n
Number of  
Responses 
 24
  25
 
“I have recently undertaken an assessment/investigation and found there was a 
lack of text with regard to forming a risk assessment.” 
 
 
 
.11 From the discussions, other reasons given for the guidance not being 
t it had been dated by 
successive organisational changes. Suggestions were made about 
duced 
 
How im
 
.12 The three foremost answers to how implementation of the guidance could 
erstanding of fabricated or induced illness and guidance in the locality 
(69%); providing training on the fabricated or induced illness guidance at 
n= 2 ) 
 
 
3
useful included its length and unwieldiness and tha
strengthening the guidance in relation to diagnostic thresholds and what to 
do at varying levels. Tools to assist with identifying fabricated or in
illness would also be welcomed.   
plementation of the guidance could be improved 
3
be improved (Figure 3),were: developing a stronger multi-agency 
und
local level (61%) and focusing on paediatricians’ experiences and views 
on the responsibilities of handling individual cases (51%).  
 
Figure 3: Ways in which implementation of guidance could be improved  
( 73
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Other  Focusing on clarity,
accessibility and
implementation of
Strengthening ways in
which the guidance is
implemented at local
Focusing
paediatrici
experiences and v
 Staff attitudes to fabricated or induced illness 
ology 
Given the social disbelief about fabricated or induced illness and 
professional debate about prevalence (see chapter 2), the survey ask
about use of terminology and confidence in dealing with suspected cas
Most respondents (88%),use the term ‘fabricated or induced illness’ but 
the majority of those who did not still used the term ‘Munchausen’s 
syndrome by proxy ‘(MSBP) or similar. Discussions suggested it was m
likely that those who had a specific remit for safeguarding or workin
directly with children wo
 
 
Termin
 
3.13 
ed 
es. 
ore 
g 
uld use the term’ fabricated or induced illness’ 
whereas for others who were not so closely connected with the issues, 
”Munchausen” or similar was still in common usage. Similar differences in 
 Unites States of America, where MSBP is 
largely used although the term “factitious disorder of childhood” is 
 
 
Confid
 
3.14 
th 
n 
ighly, so in effect like 
staff in other roles, the majority of consultant paediatricians and staff in 
specialist safeguarding roles were neither confident nor unconfident in 
dealing with cases or lacked confidence altogether. Training did not 
appear to have a bearing on confidence and comments about current 
training suggest that it needs to be more effective. 
 
 
the use of terms exist in the
increasingly preferred. 
ence in dealing with cases 
It is startling that the majority (69%) of survey respondents rated 
themselves as neither confident nor unconfident (42%) in dealing wi
cases of fabricated or induced illness or lacking in confidence altogether 
(27%). Just under a third rated their confidence highly. Consultant 
paediatricians and specialist child protection staff were more confident i
dealing with fabricated or induced illness than other professionals.  
However, only 36% and 39% of consultant paediatricians and child 
protection staff respectively rated their confidence h
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 Figure 4: Confidence of each staff group (consultant paediatricians n= 194, 
specialist child protection n= 148, other role n= 193) 
Other role 22% 41%37%
St
af
f G
ro
up
 
1-2 not confident
Specialist child protection 39% 44%17%
3 neither confident
nor unconfident
4-5 confident
Consultant paediatrician 36% 42%23%
0% 80% 90% 10% 20% 30% 40% 50% 60% 70% 100%
Percentage
 
 
 
3.15 The survey returns imply that there may be a link between knowledge of 
the guidance and confidence in dealing with cases of fabricated or induced 
illness. 91% of those who rated their confidence highly had known about 
the guidance whereas 52% of those who rated their confidence as low did 
not know about it. 
 
3.16 Experience of having dealt with a case seemed to be an important factor 
in raising confidence amongst individual respondents. 49% of all 
respondents had dealt with a case of fabricated or induced illness since 
the guidance was published in 2002. A higher proportion of 
designated/named doctors (61%) and designated/named nurses (79%) 
reported dealing with suspected cases. More than three-quarters of those 
who had dealt with a case had used the process set out in the guidance 
(Figure 5) and doing so was associated with greater confidence.  
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 Figure 5: Use of the process set out in the guidance and confidence in dealing 
with a case (n=251) 
 
 
Confidence   Use of Set Process   Confidence  
 
 
 
 
 
 
 
3.17 Team factors were also at play in the link between confidence in dealing 
with a case of fabricated or induced illness and both team and individual 
awareness of potential indicators. The more confident respondents were in 
dealing with fabricated or induced illness cases, the more likely they were 
to give their team/individual awareness of potential indicators a high rating. 
However, 39% of those who said they were not confident rated their team 
awareness as good to excellent – this may be indicative of a range of 
experience in their teams. 
 
3.18 Exploring people’s experiences in dealing with cases during the semi-
structured interviews and focus groups exposed a difference of opinion 
about the incidence of fabricated and induced illness.There were those 
who thought fabricated or induced illness was rare: 
 
“3”
55%
(32)
“1-2” not 
confident
25%
(15)
“4-5” 
confident
20%
(12) 
NO 
24%
(59)
“1-2” not confident 
6% 
(11) 
“3” 
36% 
“4-5 “ (69) 
confident  
58% 
(112) 
YES
76%
(192)
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“I am aware of the guidance and the issues. In the past five years I have not yet 
had a case where I have needed to use it.” 
 
“The incidence of FII is very small when compared to neglect. In twelve years of 
working in child protection I came across it only twice.” 
 
 
 
3.19 However, experienced doctors and nurses who had worked in child 
protection for some years believed it to be more common and had made 
clinical observations that supported their view that cases often fell in a 
continuum from mild to very severe (and rare) forms of abuse. 
 
 
 
“FII is not a rare phenomenon in my experience, though the degree may be 
enormously variable.” 
 
“The majority of cases have some elements of FII about them, but there is 
usually an underlying disorder in the child which the carers are manipulating for 
their own ends.” 
 
“Roy Meadow’s problems and his and David Southall’s GMC appeals have left 
the view that there is little or no FII and that it is professionally dangerous to 
suggest that a child is the victim of such a case.”  
 
 
 
3.20 Experienced professionals took the view that the most useful threshold 
measure to apply in cases where they had lower level concerns was 
“impairment of the child’s health and development” which is one of the key 
criteria for defining a child as being “in need” in the Children Act 1989 10.  
Use of this measure enabled them and local authority children’s services 
to assess the impact on the child of the parent/carer’s behaviour and to 
work out interventions and packages of support.  
 
 
The role of the consultant paediatrician 
 
3.21 In recognition that most consultant paediatricians will see a child whom 
they suspect some or all of their presentation of illness is being fabricated 
or induced, the guidance set out specific advice on their roles and 
responsibilities. Survey respondents were asked to consider a set of 
statements about the role of the medical consultant taken from the 
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 guidance and rate the likelihood of these practices occurring within their 
organisation.  
 
3.22 In general, there was consensus on the likelihood of the recommended 
practices occurring in respondents’ organisations. However, when replies 
of ‘not likely’, ‘neither likely nor unlikely’ and ‘don’t know’ are taken 
together, they show a mixed picture where knowledge and practice needs 
to be improved in the following areas:  
 
• The consultant paediatrician responsible for the child’s healthcare 
taking the lead responsibility rather than delegating it;  
 
• The responsible paediatrician consulting the named doctor/nurse and 
keeping them informed; and  
 
• The role of adult and forensic psychiatry in assessing the presence of 
parental mental illness.  
 
3.23 The structured conversations and focus group discussions revealed much 
richer and more frank information on some of these matters of practice:  
 
• There was a measure of confusion and uncertainty about the workings 
of the role of the consultant in charge of the child’s healthcare in taking 
the lead responsibility for clinical decisions in cases of suspected 
fabricated or induced illness because the clinical management of the 
case often became linked with the emerging child protection issues 
and role of social services; 
 
 
 
“Practically, the difficulties in this area are in the management of cases after 
diagnosis, and this varies from case to case as the child protection plan is 
managed by social services.” 
 
“The DH should make it clear that suspecting fabricated or induced illness must 
come from health and not social workers who think they know all about it.” 
 
“Social services and police should take a more active role in confirming FII. 
Suspicions or opinions are not going to work as the doctor then stands very 
isolated and at risk of a complaint from the GMC.” 
 
 
 
 
• Professionals who had been involved in cases and worked with local 
authority children’s services thought that doctors did not always 
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 understand the nature of family support work. Examples were given 
that showed that in some cases clinicians were concerned that child 
protection procedures would be instigated if they spoke to children’s 
services about possible cases, or that because diagnosis was less 
certain, children’s services might do nothing. The serious case review 
of JOT/JAT Bracknell Forest (SCR 2005/6) recommended strongly that 
doctors need to develop a better understanding of how children’s 
services work and to be clear about whether they are asking for 
support for a family (which can be provided under S17 of the Children 
Act 1989 10) or for “immediate protection” as set out in the guidance; 
 
• In spite of the level of confidence in dealing with cases of fabricated or 
induced illness reported in the survey, there was anxiety about the 
implications of diagnosing fabricated or induced illness and how this 
might impact on the individual doctor;  
 
 
 
“It isn’t a clinical issue any more, the media have taken over. If I had to do one I 
would be frightened and would do anything to avoid recrimination.” 
 
“I think the awareness of FII signs and symptoms is generally poor. This is 
compounded by fear, particularly amongst the medical profession, the 
consequences of diagnosis and the high media coverage recently given to such 
issues.” 
 
“There is a great deal of nervousness nationally within paediatrics, and this 
diagnosis is not made lightly – procedures do not protect clinicians or children if 
the legal systems are not sound.” 
 
“The fact that the GMC still pursues Prof Roy Meadows, despite the Court of 
Appeal finding him innocent, says it all. Surely no one is surprised that 
professionals now under-report cases, particularly of FII, and most juniors feel 
they will not cope with child protection issues when they become consultants.” 
 
 
 
• Nonetheless, others suggested ways in which the isolation of making a 
diagnosis could be mitigated, including more robust clinical 
supervision, consultant appraisals and in line with the current 
guidance, second opinions;   
 
 
“I should think now that most clinicians would wish for further support and a 
second opinion from a colleague.” 
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• Suggestions, including a template in the guidance to assist with 
charting accurate chronologies, were made about how the issue of 
threshold could be managed better;  
 
 
“So much depends on the threshold at which clinicians will consider FII and then 
aim to confirm or deal with it, either as a single professional or with other 
agencies. This depends on the severity and proof of the case - mild unprovable 
cases can be contained by the child’s paediatrician who maintains a regular 
follow up.” 
 
 
 
 
 
“There are degrees of FII both in suspicion and in the likely danger to the child. 
Both have to cross certain thresholds before it is appropriate to activate the child 
protection process. This should be made clear in the guidance”. 
 
 
 
Management of cases  
 
3.24 Agreement or disagreement, mainly with statements from the guidance, 
was used to establish attitudes to managing suspected cases of fabricated 
or induced illness (Figure 6). There was a reasonable level of agreement 
on how cases should be managed in respect of responsibilities for telling 
parents and children and involving children in planning and decision-
making. There was little sympathy for being “virtually certain” about 
identification of fabrication before initiating a child protection conference – 
a question brought into the survey to test attitudes about timing of referrals 
to social services. The response was slightly at odds with the disclosures 
on fear of reporting by doctors that came to light in the semi-structured 
interviews, suggesting a difference between what professionals disclosed 
in group discussions and what they did in their individual practices. Many 
professionals agreed that where a child is being maltreated, some parents 
might not change in time to prevent the child from continuing to suffer 
significant harm. Disagreement was highest about when a parent should 
be made aware of child protection concerns or when the police should be 
alerted.   
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 Figure 6:  Proportion of respondents that disagree/ agree with statements in 
questions 22 (n= 526), 23 (n= 527), 24 (n= 523), 25 (n= 527), 26 (n= 527), and 
27 (n= 527) 
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3.25 The concord in the survey results on involving children was not borne out 
in the analysis of serious case reviews. By contrast, the theme emerging 
from serious cases is the lack of involvement of the children affected. This 
critical issue has recurred throughout most analyses of child deaths from 
different forms of abuse and not just fabricated or induced illness, most 
recently in the Victoria Climbie report 4 and Westminster Child Abuse Case 
(09/02/2000). The semi-structured interviews and focus group discussions 
indicated an almost total acceptance of what the parent/carer was telling 
the medical team and the child’s voice was not being heard. Co-morbidity 
was reported as a particularly difficult factor in making a differential 
diagnosis - in some cases, the child might also have a genuine 
diagnosable health problem, such as a physical or learning disability, 
Asperger’s syndrome, autism, asthma, epilepsy or chronic fatigue 
syndrome. 
 
3.26 This issue of why the child is not heard was examined cogently in the 
serious case review report into the death of MD, a 7 year old child 33. The 
 33
 report described the notion of “the bargain of health care” as key to why 
cases of fabricated or induced illness were likely to be overlooked and the 
child’s need for protection was therefore not recognised. Professionals 
dealing with a sick child normally believe and trust the parent and mostly, 
it is the parent that tells the story about the child’s symptoms. There is an 
assumption made by doctors and health professionals that the parent 
brings the child to be made well. This unspoken “bargain” between the 
doctor and parent is challenged in fabricated or induced illness, where 
parents are out to lie, deceive or exaggerate, and thus asking the child 
may be essential to recognising the risk and doing something about it.  
 
3.27 The majority of respondents disagreed with the statement that a diagnosis 
of fabricated or induced illness had to be certain before a child protection 
conference was initiated.  However in the structured conversations and 
focus groups there was some evidence that medical teams were either 
unsure or reluctant to involve local authority children’s services in the early 
stages of a suspected case: clinicians spoke of being under pressure from 
colleagues and other agencies to make a firm diagnosis of fabricated or 
induced illness, particularly where safeguarding processes and court 
proceedings were involved. It was not always possible to be certain, and 
diagnosis might take a long time, for example if the child was referred for 
further tests or to a tertiary centre.   
 
 
 
“We need guidance about when to refer to social services and how. There is 
always the danger we will be told we should have referred earlier. We need the 
back up of the guidance to protect us from complaints by parents.” 
 
 
 
3.28 Several survey respondents, including paediatricians, agreed it was “likely 
or very likely” that once a health professional suspected fabricated or 
induced illness they would consult their clinical manager or designated / 
named doctor or nurse. From the structured interviews some respondents, 
(including the nurse groups), wanted systems in place to ensure that junior 
members of teams who had suspicions could speak up more clearly or 
were able to challenge the opinions of more senior team members. The 
serious case review analysis showed there had been cases where junior 
staff had felt suspicion or doubt about the behaviour of a parent towards a 
child and had felt unable to express this, had not been given the 
opportunity to do so or had expressed a view that was not taken on by the 
medical team. 
 
3.29 There was less agreement about whether it was crucial for any criminal 
investigation that parents were not made aware about fabrication concerns 
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 (59%) and about whether the police should be alerted to suspected cases 
as early as possible (50%). This is at odds with the process laid down in 
the guidance, but is representative of the material gathered in the 
structured conversations and focus groups, where several of those 
interviewed described situations where potential criminal proceedings had 
not commenced or been aborted because of disagreement with the police 
about how to handle the parents. Once the police were involved, there 
were examples of reluctance to engage with them about cases, for fear of 
complaints by parents. Some spoke of concerns that police might wish to 
use video surveillance techniques, which were viewed by some as 
intrusive and or “dangerous”. For example, video surveillance might be 
discovered by the parents and be destroyed or would be open to 
challenge and interpretation by the courts and was not always perceived 
as a process that would add value, or that parents may be “allowed” to 
harm the child in order to secure the video evidence, this in itself being 
dangerous to the child. In other cases, introduction of video surveillance 
by the police was described as unlikely to be acceptable to the employing 
organisations and therefore presented professionals involved in the child’s 
care with a conflict about how to proceed.   
 
3.30 Most survey respondents rated themselves (90%) and their teams (80%) 
as being “open to all possible explanations” given the difficulty in 
identification of fabricated or induced illness. The analysis of serious case 
reviews did not support such a positive picture of openness. Typically, 
there were lengthy, complex arrangements made to try to establish the 
causes of illness in the children concerned.  It was often not until a very 
late stage in the investigation and treatment of the child that fabricated or 
induced illness was considered.  A number of cases described in the 
structured conversations also showed this pattern, with some 
professionals describing how they came to think of fabricated or induced 
illness as a potential explanation for the child’s illness almost by chance.   
 
3.31 Management of suspected or cases of fabricated or induced illness is 
particularly challenging and difficult for teams who work with children. 
 
 
 
 
“I was involved in a case  …resulted in a care order on a child , who is now 
adopted and the prosecution of the mother ….at the time it was a very stressful 
experience, splitting the unit nursing staff and causing a great deal of adverse 
publicity (which was never withdrawn when the court case backed my views).” 
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3.32 41% of survey respondents had been part of a team where there had been 
conflict and this figure rose to 49% and 63% for designated/named doctors 
and designated/named nurses respectively. The guidance was reported to 
have some use in clarifying processes and furthermore, many (91%) 
thought that, as set out in the guidance, there was likely or very likely to be 
an opportunity to seek a second opinion as the route to resolving local 
disagreements.  
 
3.33 The conversations with professionals indicated a number of other 
concerns that they had:   
 
• The capacity for parents to be knowledgeable about children’s illness, 
and in cases of fabricated or induced illness to tell a more convincing 
story about the child, has been made easier by the availability of 
detailed medical and treatment information on the internet;   
 
• Some professionals get caught up in focusing on issues around 
parental intent or motivation, rather than the impact on the child, where 
they think that parental mental illness or lack of parenting skills due to 
a learning disability or personality disorder is at play. In these 
circumstances, some expressed reluctance to use the child protection 
framework, because it was thought that the parent’s intent was not 
malicious or deliberate;  
 
• Difficulties in securing the co-operation of services, especially from 
adult mental health, were also reported;  
 
 
“When involved in a case of FII we had a terrible problem trying to get a parent 
assessed for a psychiatric disorder which I am sure the mother had - we tried for 
more than a year…” 
 
 
• A commonly expressed theme was the difficulty in engaging general 
practitioners on safeguarding children and this needed to be tackled for 
cases of suspected fabricated or induced illness to be identified at an 
early stage: 
 
 
“…still very hard to engage with GPs and mental health workers in attending 
meetings as with anything to do with safeguarding children.” 
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Training  
 
3.34 Most respondents(76%) had received training on safeguarding children 
since the guidance was published in 2002. However, the lack of a link 
between attendance at training and confidence in dealing with a case 
suggests that fabricated or induced illness was either not covered in 
training or was not effectively delivered in training (Figure 8). 
 
Figure 8: Proportion of respondents who had/had not attended child protection 
training since 2002 (when the guidance was published) and level of confidence in 
dealing with FII cases (n=535) 
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3.35 All respondents (535) were asked to comment on training needs c.
The response is quite striking in embracing a full range of needs including 
training on the guidance as a whole and supporting the children and 
parents involved (Table 3). Training on the legal issues associated with 
fabricated or induced illness, assessment and diagnosis and local 
                                            
c Respondents could select more than one option. 
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 procedures and protocols for dealing with fabricated or induced illness 
were topmost. More than half of all survey respondents wanted training in 
these specific areas and at least one third of consultant paediatricians felt 
they needed such training too.  
 
3.36 Although all three staff groups had a similar pattern of training needs, a   
greater proportion of specialist child protection staff emphasised the need 
for training in the “legal issues”, “assessment/diagnosis of fabricated or 
induced illness”, “local procedures and protocols”, “supporting the children 
involved” and “supporting the parents/carers”, when compared to 
consultant paediatricians. Moreover, a greater proportion of those in the 
“other roles” group required training “on the guidance as a whole” in 
comparison to both consultant paediatricians and specialist child 
protection staff.  
 
 
Table 3: Current training needs of all respondents (n=535)  
Current Training Needs Total Responses 
(n= 535) 
Percentage of all 
Respondents (n=535) 
Other   30 6% 
No training need identified 43 8% 
On supporting the parents/carers 228 43% 
On the guidance as a whole 243 45% 
On supporting the children involved 267 50% 
Local procedures and protocols for dealing with FII 276 52% 
On assessment/diagnosis of cases of FII 284 53% 
Legal issues 355 66% 
 
 
 
3.37 400 of all survey respondents commented further on their training, of 
which 58% said that information on fabricated or induced illness was 
included. Those who received training in which fabricated or induced 
illness was included and/or found the training helpful rated their 
confidence in dealing with such cases more highly than those who said 
fabricated or induced illness was not included in the training and/or had 
not found the training helpful. Evidence from the survey suggests that 
confidence in dealing with fabricated or induced illness may be improved 
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 by improving safeguarding training to focus more on fabricated or induced 
illness. 
 
 
Figure 9: Comments on training by confidence (n=400)  
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3.38 The structured conversations and focus groups delivered a strong 
message that training on fabricated or induced illness is needed urgently, 
and that to be most effective it should be done on a multi-agency basis. 
 
 
“Needs multi-agency training so that each agency is clear about each other’s 
roles and responsibilities and holds each other to account. Single agency training 
does not address the issues effectively.” 
 
 
3.39 Others made a strong case for the subject of fabricated or induced illness 
to be included in all child protection training. 
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“It is much better, more realistic and better use of expensive resources to ensure 
that FII is included in all CP training and is not seen as something separate to 
physical abuse, emotional abuse, sexual abuse and neglect”. 
 
 
 
 
Knowledge of governance arrangements and multi-agency working  
 
3.40 The survey looked at awareness of organisational arrangements for 
monitoring and auditing compliance with the guidance on fabricated or 
induced illness. Responses suggest that most of the participating NHS 
Trusts, Primary Care Trusts or Foundation Trusts (83%) were said to have 
a Child protection/Safeguarding Committee.  
 
3.41 Only 47% of all respondents thought that advice and support was readily 
available from designated and named doctors and nurses whereas 65% of 
these specialist safeguarding professionals had thought so.  
 
3.42 There appeared to be a strong inconsistency between designated/named 
doctors’ (79%) and designated/named nurses’ (61%) understanding that 
their employing NHS organisations had local safeguarding procedures that 
included guidance on fabricated or induced illness. This may reflect poor 
or inaccurate knowledge in either group of doctors or nurses, possibly 
caused by poor access to routine information about local safeguarding 
policies and procedures. It also begs a question about access to quality 
local updates and training for this group of specialist safeguarding doctors 
and nurses.  
 
3.43 A sizeable number of designated and named professionals (36%) were 
not involved in completing their Trusts’ response to the Healthcare 
Commission’s safeguarding annual performance assessment for 2004/5 
(Figure 10). About half did not know their Trusts’ response to the question 
on fabricated or induced illness in the Healthcare Commission’s annual 
performance assessment but most of those that did agreed with it (not 
shown below).  
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 Figure 10: Designated and named professionals responses to questions on 
involvement in HCC audit and their Trust’s response (n= 196) 
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3.44 The survey looked at four aspects of multi-agency working. Respondents 
were asked to indicate the stage that their Local Safeguarding Children 
Boards (formerly Area Protection Committees) had reached with respect 
to recommendations in the guidance (Figure 12). 
 
3.45 It would seem that the following multi-agency aspects of the guidance still 
needed to be implemented fully by Local Safeguarding Children Boards: 
 
• Incorporation of the guidance on fabricated or induced illness into 
Local Safeguarding Children Boards’ procedures. From the main 
statistical report (question 39) 25% of all respondents said their Local 
Safeguarding Children Board had fully implemented this 
recommendation and it was working effectively, but 41% had no 
awareness of this development; 
 
• Information sharing protocols between agencies and professionals; 
 
• Local agreements on detailed ways of working together on fabricated 
or induced illness. 
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Figure 11: Respondents’ Local Safeguarding Children Boards’ implementation on 
FII guidance on multi-agency working (n= 535 for questions 39 to 42) 
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 Chapter 4 
 
4.0 ACTION TO IMPROVE 
IMPLEMENTATION OF 
GUIDANCE ON FABRICATED 
OR INDUCED ILLNESS 
 
4.1 The terms of reference for this review required an assessment of how 
more effective implementation could be achieved. The response rate for 
the staff attitudes’ survey is large enough to generalise the findings to the 
NHS workforce from which the sample was drawn. The structured 
conversations and focus groups provided rich material which either 
backed up the survey findings or elaborated on them. A number of 
recommendations are made in this report to improve the health services’ 
response to suspected or proven fabricated or induced illness in children 
and young people.  
 
Guidance in the NHS 
 
4.2 During the course of the review, a further opportunity arose to update the 
guidance to bring it in line with the changes to safeguarding 
responsibilities and structures brought in by the Children Act 2004 8 and 
the 2006 version of Working Together to Safeguard Children 4. The 
Government is also taking forward the relevant findings of this review to 
improve clarity of roles and responsibilities of healthcare professionals in 
the forthcoming update of the guidance on fabricated or induced illness.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 43
  
 
Knowledge, use and usefulness of guidance on fabricated or induced 
illness 
 
1. The Department for Children, Schools and Families, and  the Department 
of Health, should agree ways to promote the revised guidance on 
Safeguarding Children in Whom Illness is Fabricated or Induced so it is 
promoted extensively in the NHS and by the professional bodies. Ways 
should be found to bring it to the attention of private health providers of 
children’s services, including providers of complementary therapies.  
2. There needs to be wide-ranging readership of the guidance outside 
paediatric services. The Department for Children, Schools and Families 
and the Department of Health should consider an abridged or flowchart 
version for promotion in these various services on the basis of “what to do 
if fabricated or induced illness is suspected.” 
 
3. When revising the report, Fabricated or Induced Illness by Carers, the 
Royal College of Paediatrics and Child Health should work collaboratively 
with the Academy of Medical Royal Colleges, the Nursing, Midwifery and 
other Royal Colleges, the Royal Pharmaceutical Society and other 
relevant professional bodies to make it a shared inter-collegiate document 
that is brought to the attention of a wide range of health care staff. 
 
4. Primary Care Trusts, NHS Trusts and Foundation Trusts Boards should 
ensure that as part of working on effective arrangements within their Local 
Safeguarding Children Boards, they have robust arrangements in place for 
promoting the revised guidance, and for uptake of staff induction on 
safeguarding children and young people, which includes a focus on 
fabricated or induced illness and the role of named and designated 
professionals and how they can be contacted.    
    
 
 
 
4.3 The nature of fabricated or induced illness is such that children can 
present anywhere in the healthcare system, not always within paediatric 
services. Application of the survey results to the relevant NHS workforce 
as a whole shows that only a small minority of NHS staff have knowledge 
of the guidance, most of whom are paediatricians or specialist child 
protection nurses, and largely where they have been involved in a case of 
fabricated or induced illness. There is an on-going need to ensure that  
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 staff working with children or parents in services across the healthcare 
system, particularly within ambulatory services such as NHS Direct, 
unscheduled care, Ambulance Trusts or in important specialties such as 
pharmacy, toxicology and pathology or across private health organisations 
and providing services for children or those providing complementary 
therapies, have knowledge of the guidance.  
 
4.4 The Royal College of Paediatrics and Child Health is planning to publish a 
revised edition of its report on fabricated or induced illness 5 which clearly 
lays out the features of fabricated or induced illness and potential 
characteristics, signs and symptoms. The report is expected to link more 
coherently to the revised Government guidance and will clarify 
professional roles and clinical management of cases, highlighting the role 
of the lead paediatrician (the consultant with clinical management 
responsibility for the child where fabricated or induced illness is 
suspected) and updating on issues such as repeated medication. The 
revised report will supplement the College’s recently published Child 
Protection Companion 33. 
 
 
Identification and diagnosis of fabricated or induced illness  
 
 
5. As requested in 2006 by the Department of Health, the development of 
guidelines by the National Institute of Clinical Excellence on suspected 
child abuse should include identification of fabricated or induced illness. 
 
6. Clinical Medical Directors of paediatric services should ensure robust 
arrangements are in place in their NHS Trusts, Foundation Trusts or 
Primary Care Trusts to enable consultant paediatricians to have access to 
teams within their Trusts and across to other clinical networks outside their 
organisations, to discuss clinical concerns about identification, diagnosis 
and clinical management of fabricated or induced illness cases. 
 
7. As a general development to support more effective information on 
safeguarding children and young people, the development of the Care 
Services Improvement Partnership safeguarding children networks and 
website, and the plans to look at the feasibility of extending that beyond 
designated and named doctors and nurses to include a supra secure 
discussion forum for complex and forensic cases, is to be welcomed.  
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 4.5 Fabricated or induced illness is relatively rare and, whilst most likely to be 
seen in younger children, can also present in older children, often in 
association with underlying long term illness or disability. Clinicians who 
see children and not paediatric staff only therefore need to understand its  
presentation. The process of differential diagnosis is important in 
identifying fabricated or induced illness and the medical element of 
identification should not be left to chance or to when ‘“things are not 
adding up”. The difficulty that doctors face in obtaining evidence that the 
signs and symptoms are being fabricated or induced cannot be 
underestimated. The triangulated relationship between doctor, child  
and parent is based on trust. Suspicion of the parent or carer requires the 
suspension of that trust. A clinician’s experience in dealing with a  
case of fabricated or induced illness appears to increase confidence, 
including identification.   
 
4.6 Clinicians would benefit from sharing this expertise, in a context where 
suspected cases can be discussed and concerns raised early with peers 
and the multidisciplinary team, including local authority children’s services. 
A number of NHS Trusts have developed internal arrangements for such 
peer support on difficult aspects of child protection (Annex E). The 
formation of clinical networks 34,35 across a number of NHS Trusts will be 
another way of expanding access to experienced peers and colleagues.   
 
4.7 At regional level, the Care Services Improvement Partnership has funded 
the formation of safeguarding children networks, largely focusing on the 
needs of designated and named doctors and nurses in sharing 
information. The networks are supported by a website which includes a 
mediated password-protected discussion forum36. A feasibility study is in 
progress to examine how these electronic facilities could be used for 
discussing anonymised clinical concerns about specific cases.  
 
4.8 In 2006, the Department of Health invited the National Institute for Clinical 
Excellence: “To prepare a clinical guideline on the identification of children 
who have been subject to physical, sexual or emotional abuse or who 
have a fabricated or induced illness.” Clinicians have welcomed inclusion 
of fabricated or induced illness in the scope of the guidance which is 
expected in 2008 and will target professionals who see children but are 
not childcare experts 37. 
 
4.9 It is unacceptable that some paediatricians do not feel able to act in the 
child’s interest where there is suspicion of fabricated or induced illness, 
fearing adverse publicity, litigation and complaints unless there is a “cast 
iron guarantee” of that illness being fabricated or induced. Increasingly, 
doctors are experiencing legal action because of decisions they have  
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 taken to protect children from harm. There is a risk that this is acting as a 
deterrent to the profession as a whole when individuals are dealing with 
some cases of suspected child abuse. The UK courts have been quite 
clear in relation to the law of negligence that where professionals are 
undertaking child protection work, their first duty is to the children 
concerned.  As far as the children’s parents are concerned, professionals  
must simply act in good faith, exercising reasonable skill and care and in 
those circumstances, no duty of care is owed to the parent or carer of the 
child. In collaboration with the Royal College of Paediatrics and Child 
Health, the Department for Children, Schools and Families and the 
Department of Health have issued a joint statement on the duties of 
doctors and other health professionals in investigations of child abuse 38. 
The statement sets out the Government’s understanding of the legal 
position and outlines professionals’ duty of care and this is to be 
welcomed.  
 
 
Management of suspected cases  
 
 
8. The revision of the supplementary guidance, Safeguarding Children in 
Whom Illness is Fabricated or Induced to take account of changes to 
Working Together to Safeguard Children is timely and, in the light of the 
findings of this Review, it is welcomeed that the changes being made will:  
 
• Emphasize the necessity for all staff to be aware of their Trusts’ and 
Local Safeguarding Children policies and practices;   
 
• Clarify the co-ordinating role of the lead paediatricians vis-a-vis the 
consultant in charge of the child’s care if the consultant is not a 
paediatrician;  
 
• Include a pathways chart of responsibilities and actions to be taken 
which will cover what to do where fabrication is identified to be at the 
lower level or where the evidence of fabricated or induced illness is 
less certain;  
 
• Make more prominent in the pathways chart the need to always talk 
directly and involve the child or young person, where possible;  
 
• Affirm resolution protocols to be in place to support staff when 
professional conflict arises over identification, diagnostic and 
management decisions.  
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 4.10 In the process for identifying fabricated or induced illness, there is a need 
to improve the practical application of the roles of the medical consultant in 
charge of the child’s healthcare, the responsible paediatric consultant 
(who may also be the consultant in charge of the child’s care) and social 
services’ responsibility for making decisions about safeguarding the child. 
The lead paediatrician co-ordinates all aspects of identification, clinical 
management of the suspected case, communication with the parents, 
named and designated safeguarding professionals and links with social  
 services. Furthermore, consultant paediatricians wanted clearer guidance 
on what to do in cases where diagnosis and identification are less certain 
or are at the lower end of fabrication/harm, for example an over-anxious 
parent. The latter aspect touches on the issue of “threshold” at which to 
take safeguarding action. Threshold as perceived by paediatricians 
appears to have no consistent application between individual clinicians nor 
are the underlying concerns mutually understood by social services, who 
would emphasize that the need to safeguard a child and promote their 
welfare should not be lost through clinical uncertainty.  
 
4.11 In the context where suspicion is not clearly proven and/or harm does  
not appear to be significant experienced, clinicians would refer the child  
for a “children in need” assessment under section 17 of the Children Act 
1989 10. The process set out in existing guidance needs to be highlighted 
and supported by a pathways chart in the revised version and made more 
prominent in the revision of the Royal College of Paediatrics and Child 
Health report 5.   
 
4.12 Paediatricians and all health professionals should recognise and act on 
the need to talk to the child directly and involve them appropriately 
throughout. This is set out in the guidance but practice was wanting in the 
evidence from some of the serious case reviews.  
 
4.13 The challenge of identifying and managing suspected cases can raise 
anxieties and conflict in the teams. Dissent about causation may lead to a 
loss of focus on the child with junior staff sometimes feeling intimidated 
and isolated; this maybe compounded by poor organisational awareness 
of safeguarding arrangements in the Trust. Staff need to know that they 
can go to the named professionals for safeguarding within their 
organisation for advice and support and, if necessary, to the designated 
safeguarding professionals.This is being made clearer in the revised 
guidance. 
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 Organisational systems, governance and performance 
 
9. That the Healthcare Commission has regard for the content of this report 
in its assessment and inspection arrangements.   
 
10. As part of promoting the revised guidance on fabricated or induced illness, 
the Department for Children, Schools and Families should: 
 
 Remind Local Safeguarding Children Boards to incorporate the 
guidance into their local procedures and training, setting out in clear 
terms what is expected of adult mental health services, primary care 
and general practice and collaboration with the police and other 
agencies. 
 
 Ask Local Safeguarding Children Boards to ensure that their members, 
including Primary Care Trusts, NHS Trusts and Foundation Trusts, 
bring the guidance to the attention of all their staff, in accessible 
formats, promoting the pathways chart on fabricated or induced illness 
to clinicians and staff in all age specialties and services where children 
and young people are seen. 
 
 
 
4.14 All health organisations, whether in the NHS or independent health care 
sector, are required to ensure safeguarding children is an integral part of 
their governance systems. It was not clear from this review whether such 
processes were in place within all organisations or who had responsibility 
for monitoring these processes, with many of those responding to the 
survey or interviewed, being unclear about or unaware of how these 
processes functioned within their organisation. Improving patient safety is 
a key concern of provider healthcare organisations, and the governance 
arrangements that Boards of healthcare organisations put into place for it 
should take account of safeguarding children more generally, and the 
particular systemic risks to fabrication or induction of illness in children and 
young people who are receiving hospital care (see paragraph 2.19).  
 
4.15 Understanding fabricated or induced illness reaches beyond paediatricians 
and child health; because of the wide-ranging symptoms with which 
differing manifestations may present and the potential repetition of surgical 
and diagnostic interventions, professionals in other adult healthcare  
services where children or young people are seen need to know what to 
look out for and how to refer, where appropriate.  
 
4.16 Where parental or a carer’s mental illness might be an issue, the difficulty 
of engaging adult and forensic psychiatry in assessing for the presence of 
a mental illness or in recognising the need of the children involved is a 
recurrent theme of the serious case reviews analysed. This is a common 
concern in safeguarding children from all forms of abuse. Similar issues of 
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 engagement with GPs were reported in the survey follow-up telephone 
conversations. There were too few GPs in the review to draw any 
inference but the insights they gave suggested that limited knowledge 
about local safeguarding arrangements and fabricated or induced illness 
sometimes act to dampen co-operation with other healthcare professionals 
and children’s services. However, as part of the primary care team, health 
visitors and school nurses play a significant role in child protection and are 
able to support GPs and paediatricians in the process.  As providers of a 
universal primary preventive service, health visiting teams see children in 
a family and social context. This gives them a key role in identifying 
possible cases of fabricated or induced illness at an early stage and 
providing some of the support that could prevent an escalation of the 
problem. Evidence from the Nurse Family Partnerships in the United 
States, which is being tested in 10 sites in England, was shown through 
three large-scale trials to reduce abuse and neglect in children 40,41.   
 
4.17 Inappropriate use of or frequent requests for medicines may be one of the 
manifestations of repeated use of health services for some fabricated or 
induced illness presentations. This may require action at several levels: 
where fabricated or induced illness is suspected, as a preventive measure, 
reviews of repeat prescribing for long-term conditions such as epilepsy or 
diabetes or accurate history-taking and accessing a range of notes held by 
prescribers, for example, in accident and emergency, walk-in centres, 
community. 
  
4.18 The repeated use of health services, which may characterise some forms 
of fabrication, may be made easier with the multiplicity of  
ambulatory care options now available. The coming into being of the 
electronic national care record NHS Care Record Service and associated 
Secondary User Uses Service in conjunction with ContactPoint 42 (an 
information sharing index) should enable clinicians to examine the pattern 
of health services’ use where there are concerns about fabrication or 
induction. 
  
4.19 Patient safety systems play a key part in supporting care that saves lives 
and prevents harm to people receiving NHS care. Safeguarding children 
and young people in hospital care, in terms of reducing risks in systems of 
care, should be integral to promoting patient safety and reporting and 
learning from adverse events. The needs of children should be identified 
and addressed in taking forward the implementation of Safety First: A 
report for patients, clinicians and healthcare managers 39. 
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 Education and training  
 
 
11. Widely promote the Department for Children, Schools and Families’ 
forthcoming training resources on fabricated or induced illness, Incredibly 
Caring DVD, which is designed to assist with local implementation of the 
revised guidance on Safeguarding Children in Whom Illness is Fabricated or 
Induced. 
 
12. When the revised guidance is published, Local Safeguarding Children Boards 
should be asked to ensure that their multi-disciplinary and inter-agency 
safeguarding training programmes include fabricated or induced illness. 
 
 
 
 
4.20 Working Together to Safeguard Children 4 provides guidance on    
training and development of staff in strategic and operational roles and on 
a single and multi-agency basis. Multi-agency approaches are required to 
promote a common and shared understanding of the roles,  
responsibilities and contributions of different organisations and 
professionals. Additional training is needed on the clinical aspects to meet 
the specialist needs of the different health disciplines. The review findings 
suggest that confidence in dealing with cases of fabricated or induced 
illness is improved by training, and particularly on a multi-agency basis. 
Furthermore, people thought fabricated or induced illness should be 
included in general training on safeguarding children. 
 
4.21 A training package will be launched with the revised guidance on 
fabricated or induced illness to support its implementation. 
 
 
 
The evidence base 
 
4.22    “Diagnose and be damned, don’t diagnose and be damned” is indicative of 
the dilemma that fabricated or induced illness can sometimes present to 
doctors. A lucid evidence base is critical for differential diagnosis of the 
clinical presentation, for example in cases of induced illness, between 
neglect and organic causes of failure to thrive or between induced illness 
and rare or unusual medical disorders neglect. Previously contentious   
 conditions such as chronic fatigue syndrome have in the past benefited 
from delineation from fabricated or induced illness through improved 
guidelines on diagnosis and clinical management.  
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 4.23 This report makes no new proposals because a number of initiatives are 
underway which would improve the evidence base for practitioners. The 
National Institute for Clinical Excellence guidelines on recognition of 
suspected child abuse is expected to be published in 2008. In addition, a 
jointly funded safeguarding research initiative will deliver a range of 
evidence-base guidelines to inform both clinical and interdisciplinary 
professional practice in the area of neglect, emotional abuse and the 
impact of interventions. Other important outputs from this initiative, which 
will address a range of concerns pertinent to fabricated or induced illness, 
include:  
 
• Best practice on how GPs manage conflicts of interest between family 
work and acting in the best interests of a child at risk to significant 
harm; 
 
• Good practice on communication in the light of parents’ experiences of 
being suspected of child abuse; 
 
• Tools for Local Safeguarding Children Boards to evaluate the 
effectiveness and impact of their training programmes. 
 
4.24 Finally, proposals in Bearing Good Witness 43 for a national knowledge 
service to help improve the evidence base available to medical expert 
witnesses should, when established, assist in providing an up-to-date 
analysis of the facts in some of the difficult areas of clinical diagnosis and 
management.   
 
 
 
Conclusion 
 
4.25  Fabricated or induced illness is a form of child abuse occurring across a    
spectrum of presentations. A major problem and a common factor 
identified in public inquiries and serious case reviews of child abuse over 
the past three decades is that quite often, existing guidance and 
procedures have not been followed. The key issues these inquiries have 
raised include difficulties with multi-agency working and training, poor or 
non-existent area-wide safeguarding/child protection procedures, poor 
communication and poor clarity about responsibilities.  
 
4.26 This review has highlighted similar findings and furthermore highlights the 
challenging and difficult nature that clinicians experience in identifying and 
managing cases. It is clear that some modification is needed to current 
guidance to clarify roles and responsibilities in clinical management in the 
healthcare sector and decisions about safeguarding. However, Primary 
Care Trusts, NHS Trusts and Foundation Trusts also need to play their 
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 part in the work of Local Safeguarding Children Boards to ensure that the 
governance, procedural and training arrangements agreed for 
safeguarding children and young people from fabricated or induced illness 
are in place and working well. Local Safeguarding Children Boards are the 
cornerstone in co-ordinating the work of agencies and professionals in 
safeguarding children and young people and minimising risks to harm. 
Strategic Health Authorities, Primary Care Trusts, NHS Trusts and 
Foundation Trusts are statutory members of the Boards. The 
recommendations of the review report need to be reflected in the 
development of their work.  
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Anne Green Consultant Biochemist, Director of Neonatal Screening and Inherited 
Metabolic Disorders Services, Birmingham Children's Hospital 
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Danya Glaser Child and Adolescent Psychiatrist, Great Ormond Street Hospital 
Jean Price Community Paediatrician, Southampton Designated Doctor with 
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Dr. Rosalyn Proops Named Doctor with experience of fabricated or induced illness 
Fiona Smith Royal College of Nursing 
Gwen Adshead Adult Psychiatrist, Broadmoor, Berkshire 
Harvey Marcovitch Paediatrician 
Ian Wong Director, Centre for Paediatric Pharmacy Research 
Jan Horwath Professor of Child welfare, Sheffield University 
Jane Ratcliffe Paediatric Intensive Care Society, and Alder Hey Children's Hospital 
Karen Carruthers Social Worker with experience of fabricated or induced illness 
Kathy Dickinson National Clinical Governance Support Team  
Kathy James National Association of Head Teachers 
Lucy Thorpe Policy Advisor, National Society for Protection of Cruelty to Children 
Maddie Blackburn Healthcare Commission 
Mary Eminson Child and Adolescent Psychiatrist 
Neela Shabde Named Doctor with experience of fabricated or induced illness 
Pauline Lambert Designated Nurse with experience of fabricated or induced illness 
Peter Fleming Paediatrician, Bristol 
Adrian Newland Royal College of Pathologists 
Rob Grinsted Royal College of General Practitioners  
Sheila Adam Director of Public Health, NE London SHA 
Terence Stephenson National Patient Safety Agency 
Terry Grange Association of Chief Police Officers, Chief Constable, Wales  
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Annex B: 
 
Summary of methodology for gathering evidence 
 
The review’s methodology consisted of four components: 
 
• A web-based anonymous staff attitude survey (and where the respondent 
agreed a follow-up telephone conversation); 
 
• Structured conversations; 
 
• Case analysis of serious case reviews; and 
 
• A broad range of multi-professional focus groups. 
 
The web based survey/follow-up conversations were conducted to establish the 
extent of the awareness of existing fabricated or induced illness guidance, how 
staff use the guidance, what helps and what more can be done to achieve 
effective implementation. A wide range of health and social care professionals 
(including managers) were targeted through internal and external bulletins, 
newsletters and through the Royal Colleges and professional bodies.  
 
Of the 30 or so respondents to the survey who indicated a willingness to 
participate in a follow-up telephone interview 22 were interviewed by phone (the 
others being unavailable in the timescales) and included consultant 
paediatricians and psychiatrists, named and designated doctors and nurses, 
GPs, and social workers. 
 
Structured conversations A further 21 semi-structured interviews or 
conversations were undertaken with staff from teams who have been involved in 
fabricated or induced illness work with a particular focus on paediatricians.  
Participants were identified through the Advisory Group members and other 
professional links. 
 
An analysis of serious case reviews was planned to examine 10 serious case 
overview reports available in the public domain, since the guidance was 
published in 2002.  Requests for assistance in identifying reviews were made to 
the Department for Education and Skills, Commission for Social Care Inspection, 
Advisory group members and a range of professional bodies. In the event, only 
four serious case reviews’ overview reports were forthcoming.  
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 Focus groups were used to test the emerging themes from the staff attitude 
survey and semi-structured interviews. Seven meetings were held with multi-
agency professional groups in different areas of the country including GPs, 
accident and emergency consultants, education and children’s social care 
professionals. 
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 Annex C: 
 
Online survey of staff attitudes - organisation type definition and 
number of respondents 
 
 
Organisation type Organisation respondents work for Number of 
respondents
NHS Trusts Acute NHS Trust 254
  Children’s NHS Trust 19
  Foundation Trust 23
  Other NHS Trust 1
Acute Total   297
PCT Health and Social Care Trust 5
  
Multi-agency or Children’s Trust 
arrangement 3
  Partnership arrangement  3
  Primary Care Trust 179
 Other PCT 3
PCT Total   193
Other  Combined Social Services/Education 4
  Education 4
  General Practice 4
  Independent sector 2
  Mental Health Trust 14
  Social Services 4
  Sure Start 1
  Voluntary organisation 1
 Other Organisation Type 11
Other  Total   45
Total respondents   535
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Annex D: 
 
Online survey of staff attitudes - staff group definitions and 
number of respondents 
 
Staff Group Respondent’s Job Title 
Number of 
Respondents 
Consultant paediatrician 
Consultant paediatrician – community 
based 58
  Consultant paediatrician – hospital based 129
  Other consultant paediatric medical role 7
Consultant paediatrician Total 194
Specialist child protection  
Child protection  adviser/manager of a CP 
team  24
  Consultant – nurse  15
  Health visitor 48
  School nurse 13
  Other specialist child protection 43
Specialist child protection Total  143
Other role Allied health professional  4
  Career grade paediatrician 15
  Consultant – CAHMS 2
  Consultant – forensic psychiatry 1
  Consultant – medical 1
  Consultant – nurse  4
  General practitioner 9
 Midwife 5
  Other non-consultant paediatric role 8
  Practice nurse 1
  Registered children’s nurse 41
  Registered learning disabilities nurse 1
  Registered mental health nurse 3
  Registered nurse 13
  Senior House Officer - paediatrics 5
  Social services – other 5
  Social work team leader  2
  Social work team leader in community  2
  
Social worker based in a hospital working 
with children 1
  Specialist registrar in paediatrics 41
 Other role- not listed 34
Other role total   198
Total respondents   535
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Annex E: 
 
Examples of Good Practice 
 
 
1. Local Safeguarding Children Board, London Borough of Harrow 
 
The London Borough of Harrow and relevant NHS Trusts have worked 
together to create a senior group of doctors, nurses and other relevant  
professionals to form a group that staff can use for consultation when NHS 
staff or other professionals have concerns that a case may be  fabricated 
or induced illness. To support this work, they have developed a protocol 
which explains how professionals can access this group and what it can 
offer. The group also play a role in providing support for members of staff 
who are involved in cases of fabricated or induced illness which they do 
either directly or by ensuring that this is provided by an appropriate 
person. 
 
In a similar way, Brighton and Hove Children and Young People’s Trust 
are developing a reference group for discussing cases of fabricated or 
induced illness 
 
2. Southampton Primary Care Trust and Southampton University Hospitals  
Trusts (SUHT) 
 
These two organisations have developed local systems to ensure that 
there is multi-professional liaison between community paediatricians and 
community staff and their acute hospital trust colleagues. Agreement has 
been reached that where there are concerns about a child, the child will 
always be admitted to hospital under the same consultant paediatrician. 
 
The Designated and Named professionals for child 
protection/safeguarding are involved from the earliest stage in all cases of 
actual or potential fabricated or induced illness and facilitate child 
protection strategy meetings, staff support and reflective practice groups. 
The fabricated or induced illness child protection strategy meetings are 
always chaired by a senior Social Worker and attended by a D.S. or above 
from the local police Child Abuse Investigation Unit along with the 
Designated and Named child protection professionals. Multi-agency, 
combined family chronologies are produced in all such cases. Awareness 
has been successfully raised amongst staff via training on the SUHT 
monthly child protection professional study days leading to earlier 
identification of such cases. Topic specific Fabricated or Induced Illness 
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 half study days are planned for 2008 to further raise awareness amongst 
hospital staff. 
 
 
 
3. Central Manchester and Manchester Children’s University Hospitals 
NHS Trust 
 
These two trusts have produced guidelines for the management of 
fabricated and induced illness which contain an audit tool with related 
standards for managing cases, a template for creating chronologies and 
specific guidance about the handling of individual cases. These have been 
distributed to Primary Care Trusts in the area. 
 
 
4. Hertfordshire County Council and their local area child protection 
committee (now Local Safeguarding Children Board)  
 
Working together, these organisations have worked with key professionals 
in their local area to raise awareness of fabricated or induced illness. They 
have encouraged the development of a best practice approach by 
wherever possible convening early multi-agency “professionals” meetings 
to consider cases where fabricated or induced illness may be a possibility. 
They have found it is essential that all key professionals, including the GP 
and any consultants who have worked with the child, attend this meeting 
and contribute to the creation of a chronology. The police are also invited 
to attend. The meeting is chaired by a senior officer with safeguarding 
knowledge and would not include parents but a key part of the meeting 
would be to agree what needs to be done about informing and involving 
them. These meetings are not easy to set up and administer but have 
been found to be invaluable in promoting a focus on the needs of the child  
and encouraging sharing between agencies about how to proceed. 
 
 
5. Template for cases of fabricated or induced illness 
 
The serious case review report to the Cumbria Child Protection committee 
(March 2004) contains a useful template “Warning signs of fabricated or 
induced illness”. This was produced by the serious case review group who 
worked on the case of MD and is designed to “trigger” a professional into 
realising that things are not quite right and to give an indication as to 
whether fabricated or induced illness is a possibility.   
 
www.cumbrialscb.com/pagesall.aspx?id=296
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 6. Policies for working with possible/actual cases of fabricated or induced 
illness when children are in hospital - Great Ormond Street 
 
Great Ormond Street Hospital for Sick Children has developed a number 
of  policies and procedures to support their staff in working with cases of 
or potential cases of fabricated or induced illness. These include a general 
policy on the management of fabricated or induced illness in the acute 
setting and a policy on observation and supervision of children.   
 
Contact: Admin Manager 
Psychosocial and Family Services/Child Protection 
020 7405 9200 ext 1127 
GuthrC@gosh.nhs.uk  
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